|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12N 15/09 | (2006.01) |
| A61K 38/46 | (2006.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61K 35/12 | (2015.01) | ||
| A61K 35/28 | (2015.01) | ||
| C07K 14/47 | (2006.01) | ||
| C12N 9/22 | (2006.01) | ||
| C12N 15/113 | (2010.01) |
| (11) | Number of the document | 3492593 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18214711.6 |
| Date of filing the European patent application | 2014-11-13 | |
| (97) | Date of publication of the European application | 2019-06-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-18 |
| (46) | Date of publication of the claims translation | 2021-11-25 |
| (30) | Number | Date | Country code |
| 201361903823 P | 2013-11-13 | US | |
| 201462042075 P | 2014-08-26 | US |
| (72) |
ORKIN, Stuart H. , US
REIK, Andreas , US
URNOV, Fyodor , US
|
| (73) |
Children's Medical Center Corporation ,
55 Shattuck Street, Boston, MA 02115,
US
Sangamo Therapeutics, Inc. , 7000 Marina Blvd, Brisbane, CA 94005, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Nukleazės sąlygojama genų raiškos reguliacija |
| NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION |
| Payment date | Validity (years) | Amount | |
| 2023-10-18 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-11-13 |